SEC Filings

Filing date Description Form Filing Group View

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
View HTML

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
View HTML

An annual report to security holders

ARS
Annual Filings
View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
Other
View HTML

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

144
Other
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.